First study finds CBN improves sleep without intoxicating effects
A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep in rats.
24 results for “cbn”
A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep in rats.
New findings suggest promise for CBN in treating neurological disorders like traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.
CBN, CBC and CBDa are just some of the cannabinoids with huge potential for our health and wellbeing.
Researchers found that CBN promotes neuroprotection and helps normalise pressure in the eyeball.
A new study suggests CBN has the potential for treating age-related neurodegenerative diseases.
A new partnership between CBDistillery and ReLeaf App examined CBD and CBN for sleep with plans for more studies to follow
Participants slept on average 20 minutes longer while taking the tablet
New research will assess the potential of cannabinoids CBD and CBN for improving sleep and reducing anxiety.
Scientists in the US believe they have discovered a novel way of producing the lesser-known cannabinoid CBN, which could have major implications to the cannabis products market.
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
Data collected from 25,000 older adults shows cannabis use may be linked to slower brain ageing and improved cognitive function.
The event will focus on the medicinal use of cannabis in chronic neurodegenerative diseases.
Almost 400 families were found to be sourcing illegal cannabis products having been unable to get a prescription on the NHS.
CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer.
An expert explains everything you need to know about the entourage effect.
Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to find the right dose.
Explore the reported benefits, the latest research and where you can find it.
Only 8% products had concentrations within 10% of the advertised strength.
29.6 million people in the UK could be eligible for medical cannabis, but less than 1% have access to a prescription.
Catch up on some of the latest research exploring the therapeutic potential of cannabis.
The country has seen some major developments across the medicinal cannabis, industrial hemp and CBD sectors.